Saffar I - Search Results

1

Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases.

Chaudhary V, Mar F, Amador MJ, Chang A, Gibson K, Joussen AM, Kim JE, Lee J, Margaron P, Saffar I, Wong D, Wykoff C, Sadda S. Chaudhary V, et al. Among authors: saffar i. Graefes Arch Clin Exp Ophthalmol. 2024 Dec 21. doi: 10.1007/s00417-024-06695-4. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39708087 Review.

2

What is Occluding Our Understanding of Retinal Vein Occlusion?

Dinah C, Chang A, Lee J, Li WW, Singh R, Wu L, Wong D, Saffar I. Dinah C, et al. Among authors: saffar i. Ophthalmol Ther. 2024 Dec;13(12):3025-3034. doi: 10.1007/s40123-024-01042-6. Epub 2024 Oct 10. Ophthalmol Ther. 2024. PMID: 39387960 Free PMC article. No abstract available.

3

Clinical Outcomes and Experiences with Prefilled Syringes Versus Vials for Intravitreal Administration of Anti-VEGF Treatments: A Systematic Review.

Uzzan J, Mapani A, Cox O, Bagijn M, Saffar I. Uzzan J, et al. Among authors: saffar i. Ophthalmol Ther. 2024 Sep;13(9):2445-2465. doi: 10.1007/s40123-024-01002-0. Epub 2024 Jul 27. Ophthalmol Ther. 2024. PMID: 39066961 Free PMC article.

4

Effect of Brolucizumab and Aflibercept on the Maximum Thickness of Pigment Epithelial Detachments and Sub-Retinal Pigment Epithelium Fluid in HAWK and HARRIER.

Khanani AM, Sadda SR, Sarraf D, Tadayoni R, Wong DT, Kempf AS, Saffar I, Gedif K, Chang A. Khanani AM, et al. Among authors: saffar i. Ophthalmol Retina. 2024 Jul 19:S2468-6530(24)00335-X. doi: 10.1016/j.oret.2024.07.012. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39033924 Free article.

5

Infographic: study design of the BALATON and COMINO phase 3 randomised trials of faricimab in patients with retinal vein occlusion.

Chang A, Kotecha A, Kermani F, Saffar I. Chang A, et al. Among authors: saffar i. Eye (Lond). 2024 Aug;38(Suppl 2):55-56. doi: 10.1038/s41433-024-02936-2. Epub 2024 Feb 23. Eye (Lond). 2024. PMID: 38396033 Free PMC article. No abstract available.

6

PIGMENT EPITHELIAL DETACHMENT THICKNESS AND VARIABILITY AFFECTS VISUAL OUTCOMES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Sarraf D, Khanani AM, Sadda SR, Chang A, Wong DT, Kempf AS, Saffar I, Tang S, Tadayoni R. Sarraf D, et al. Among authors: saffar i. Retina. 2024 Jan 1;44(1):10-19. doi: 10.1097/IAE.0000000000003935. Retina. 2024. PMID: 37824807

7

Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER.

Sadda S, Sarraf D, Khanani AM, Tadayoni R, Chang AA, Saffar I, Gedif K, Wong DT. Sadda S, et al. Among authors: saffar i. Br J Ophthalmol. 2024 May 21;108(6):852-858. doi: 10.1136/bjo-2023-323577. Br J Ophthalmol. 2024. PMID: 37669850 Free PMC article. Clinical Trial.

8

Treatment patterns in patients with age-related macular degeneration and diabetic macular edema: A real-world claims analysis in Dubai.

Kozak I, Gurbaxani A, Safar A, Rao P, Masalmeh A, Assaf H, Farghaly M, Pathak P, Natarajan A, Saffar I. Kozak I, et al. Among authors: saffar i. PLoS One. 2021 Jul 13;16(7):e0254569. doi: 10.1371/journal.pone.0254569. eCollection 2021. PLoS One. 2021. PMID: 34255798 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters